Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
Clinical trial NCT03476109 · UNKNOWN
Trial details
- NCT number
- NCT03476109
- Sponsor
- Cliniques universitaires Saint-Luc- Université Catholique de Louvain
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-10
- Primary completion
- 2023-12-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.